Influenza Vaccine Cold Chain Guide: Storage and Transport

As seasons change and temperatures drop, preparations for flu season begin. When immunization efforts start, influenza vaccines are protected by cold chain measures from the moment they leave the facility.

After the influenza vaccine leaves the manufacturer, the process is designed to maintain the temperature at which the vaccine remains effective. A critical part of the immunization process involves the use of refrigeration technology and specialized temperature monitors to ensure stable temperature conditions from manufacturing to administration.

To better understand how the influenza vaccine cold chain works, let's review the processes, regulations, and practices required to ensure vaccines reach patients safely.

Overview of the Influenza Vaccine Cold Chain

The influenza vaccine cold chain is a temperature-controlled supply chain that ensures the storage and transport of the vaccine from the manufacturer to the point of administration. This involves continuously maintaining temperature conditions that preserve the vaccine's potency and effectiveness.

With the upcoming flu season approaching, understanding and adhering to the influenza vaccine cold chain process is crucial for pharmaceutical companies and healthcare providers.

Ideal Temperatures During Influenza Vaccine Storage and Transport

Influenza vaccines must be maintained at temperatures between 2°C and 8°C (35°F to 46°F) during storage and transport. Deviations from this range, such as freezing temperatures, can compromise the vaccine's integrity, rendering it ineffective.

Best Practices for Influenza Vaccine Transport

When transporting influenza vaccines, several practices can help maintain the cold chain and ensure vaccine effectiveness:

Load Products at the Correct Temperature

Vehicles and insulated containers used for vaccine transport should be pre-conditioned to the appropriate temperature before packaging and loading to ensure the influenza vaccine is not exposed to temperatures outside the recommended range. This initial step prevents temperature excursions at the start of the journey.

Avoid Placing Products Near Truck Walls

Truck walls are more susceptible to external temperature fluctuations, so vaccine products should not be placed near the walls. Keeping the walls clear also improves airflow, ensuring more stable temperatures during transit.

Consider the Truck Route

External weather conditions can affect internal temperatures, but this can be mitigated with good planning. For example, for shipments traveling from north to south in the Northern Hemisphere, the rear of the truck will face the sun during transit. Extra care should be taken when loading the truck and setting up temperature monitoring to mitigate potential temperature fluctuations.

For longer cross-country trips, drivers may reach their driving time limit (typically ten hours) before delivery is complete. A plan should be in place to either switch drivers or set up contingency measures to maintain temperature during driver downtime.

Ensuring the Influenza Vaccine Stays Within the Appropriate Temperature Range

It is critical to ensure the influenza vaccine remains within the proper refrigerated temperature range, typically 2°C to 8°C (35°F to 46°F). Exposure to temperatures outside this range can affect vaccine stability, rendering it ineffective or even harmful. Many vaccines, including influenza vaccines, become unusable and must be discarded after exposure to freezing temperatures. This is a common cause of vaccine waste: one study found that 16.7% of vaccines were accidentally frozen during transport.

To maintain the correct temperature range, qualified refrigeration equipment must be used, and validated, accurate temperature monitors must be employed to ensure the cold chain is maintained during transport and storage between the manufacturer and the administering facility. All refrigeration equipment should be set to 5°C, the midpoint of the acceptable range.

Ensure Vaccines Do Not Come into Direct Contact with Ice

Influenza vaccines, like many other refrigerated vaccines, are susceptible to degradation when exposed to freezing temperatures. Storing or transporting influenza vaccines in direct contact with ice or frozen gel packs significantly increases the risk of freezing and must be avoided. Ensure proper insulation and separation to prevent direct contact between the vaccine and ice.

Invest in Real-Time Monitoring to Prevent Supply Chain Disruptions

While vaccines are often shipped with simple electronic indicators to show whether temperatures were maintained during transit, real-time monitoring solutions such as the TempTale GEO Ultra® can alert logistics and pharmaceutical companies immediately when temperature issues occur, providing an opportunity for intervention and preventing wasted shipments. Similarly, digital solutions like Lynx Logix™ help predict supply chain disruptions, and real-time fixed monitoring solutions such as ColdStream® can continuously monitor temperatures during storage, providing actionable alerts and insights.

These solutions also leverage the detailed data they provide to optimize shipping lanes or storage areas, helping prevent future temperature issues.

Best Practices for Influenza Vaccine Storage

Proper storage is essential for maintaining the effectiveness of influenza vaccines. Here are some storage best practices:

Designate a Dedicated Refrigerator for Influenza Vaccines

The U.S. Centers for Disease Control and Prevention (CDC) recommends a dedicated refrigerator for vaccine storage only. This must be a standalone unit that provides more stable temperature control and reduces the risk of freezing during storage.

While household-grade refrigerators can be used if necessary, refrigeration units designed for biological products offer better air circulation, more uniform temperatures, and faster recovery to the correct temperature. Temperatures in all influenza vaccine storage units must be monitored.

Identify Areas Prone to Temperature Fluctuations

Thermal mapping studies, sometimes called temperature mapping studies, involve placing temperature monitoring sensors throughout a storage area to identify temperature fluctuations. This process helps identify areas susceptible to temperature variations, enabling better temperature control. Thermal mapping is a regulatory requirement for vaccine storage in many parts of the world.

Have a Plan if Vaccine Temperatures Go Out of Range

It is important to have a contingency plan for when vaccine temperatures go out of range. This can prevent vaccine waste or the administration of ineffective vaccines.

Avoid Light Exposure

Light exposure can affect vaccine stability. Therefore, it is best practice to avoid light when storing or transporting influenza vaccines.

Both the CDC and the UK's National Health Service (NHS) recommend storing vaccines in their original packaging, which protects them from light, facilitates inventory management, and ensures the temperature range indicated on the manufacturer's label remains clearly visible.

Inventory Control

Limiting inventory is a waste-reduction practice for all vaccines. The Rhode Island Department of Health's Vaccine Handling and Storage Guidelines recommend maintaining a two-to-four-week supply of influenza vaccine doses to prevent expiration. Note that this is shorter than for other vaccines, and existing processes may need to be updated.

Influenza Vaccine Cold Chain Regulations

Influenza vaccines are subject to regulations that provide overarching principles for proper vaccine storage and handling, such as temperature control, inventory management, storage equipment requirements, and documentation procedures.

The specific regulations applicable vary depending on the region where the influenza vaccine is transported or stored. However, it is important to be familiar with the EU GDP guidelines, USP <1079>, USP <659>, the CDC's Vaccine Storage and Handling Pink Book, and the World Health Organization's guidelines on vaccine packaging and transport. All these documents detail regulatory requirements and best practices for vaccine transport and storage.

Common components of each document include:

Always maintaining the influenza vaccine at the required temperature using appropriate equipment

Monitoring vaccine temperature with high-precision temperature monitors with calibration certificates

Properly documenting any excursions or temperature issues

Transporting using qualified insulated packaging

Storing influenza vaccines in a dedicated refrigerator with precise temperature monitoring

Qualification of shipping lanes and thermal mapping of storage environments

Experts can provide more comprehensive guidance to help determine whether your vaccine storage program meets regulatory requirements.

Summary

Maintaining the integrity of the influenza vaccine cold chain through proper storage and transport practices is essential. Following recommended guidelines, investing in temperature monitoring systems, and staying compliant with regulations will contribute to a successful influenza vaccination campaign.

We offer a range of vaccine temperature monitoring solutions, from WHO-approved electronic indicators to real-time visibility and facility monitoring.

Contact us to learn how our monitoring solutions and expertise can support your pharmaceutical cold chain operations.